• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The use of continuous culture to enhance monoclonal antibody production.

作者信息

MacMichael G J

机构信息

Techne Incorporated, Princeton, NJ 08540.

出版信息

Hybridoma. 1989 Feb;8(1):117-26. doi: 10.1089/hyb.1989.8.117.

DOI:10.1089/hyb.1989.8.117
PMID:2925207
Abstract

Hybridoma 14-4-4S, ATCC HB32, was grown in batch and continuous culture in an attempt to increase the production of monoclonal antibody (MAb), and to determine the adequacy of each culturing method for optimizing culture media. Various concentrations of glucose, fetal bovine serum (FBS) and serum type were studied to determine their effects on the specific growth rate (mu), the specific monoclonal antibody production rate (MPR), the maximum population density and the final MAb concentration. Attempts to optimize the culture medium using the batch method resulted in ambiguous results. However, by growing the hybridoma in a cytostat at a standardized population density of 1.0 X 10(6) cells/ml, the growth rate and MPR were found to decrease below feed concentrations of glucose and FBS of 22.5 mM and 10% (v/v), respectively. In addition, the use of the cytostat demonstrated that FBS was superior to both new born bovine serum (NBS) and Serum PlusTM (SPS). Batch cultures indicated that the production of MAb appeared to be related to the metabolic activity of the cells, and continuous culture demonstrated a direct relationship between mu and MPR.

摘要

相似文献

1
The use of continuous culture to enhance monoclonal antibody production.
Hybridoma. 1989 Feb;8(1):117-26. doi: 10.1089/hyb.1989.8.117.
2
Effect of serum concentration on hybridoma cell growth and monoclonal antibody production at various initial cell densities.
Hybridoma. 1989 Jun;8(3):369-75. doi: 10.1089/hyb.1989.8.369.
3
The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.在悬浮培养和固定化培养的生长停滞杂交瘤中产生单克隆抗体。
Biotechnol Prog. 1999 Jul-Aug;15(4):655-66. doi: 10.1021/bp990068m.
4
Factors affecting monoclonal antibody production in culture.影响培养中单克隆抗体产生的因素。
Dev Biol Stand. 1987;66:169-75.
5
Growth of hybridoma cells and antibody production in agamma calf serum.杂交瘤细胞在无γ小牛血清中的生长及抗体产生
Hum Antibodies Hybridomas. 1992 Oct;3(4):206-11.
6
Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 2. Effects of serum concentration, dissolved oxygen concentration, and medium pH in a batch reactor.杂交瘤细胞培养的生长、代谢及抗体产生动力学:2. 分批反应器中血清浓度、溶解氧浓度及培养基pH值的影响
Biotechnol Prog. 1991 Nov-Dec;7(6):481-94. doi: 10.1021/bp00012a002.
7
Role of metabolic waste products in the control of cell proliferation and antibody production by mouse hybridoma cells.
Hybridoma. 1992 Jun;11(3):311-22. doi: 10.1089/hyb.1992.11.311.
8
Methods for increasing monoclonal antibody production in suspension and entrapped cell cultures: biochemical and flow cytometric analysis as a function of medium serum content.提高悬浮培养和包埋细胞培养中单克隆抗体产量的方法:作为培养基血清含量函数的生化和流式细胞术分析
J Biotechnol. 1990 Jul;15(1-2):71-89. doi: 10.1016/0168-1656(90)90052-d.
9
Differences in the glycosylation profile of a monoclonal antibody produced by hybridomas cultured in serum-supplemented, serum-free or chemically defined media.在补充血清、无血清或化学成分确定的培养基中培养的杂交瘤产生的单克隆抗体的糖基化谱差异。
Biotechnol Appl Biochem. 2007 Jun;47(Pt 2):113-24. doi: 10.1042/BA20060216.
10
Comparison of specific rates of hybridoma growth and metabolism in batch and continuous cultures.分批培养和连续培养中杂交瘤生长和代谢的比速率比较。
Cytotechnology. 1992;10(2):147-55. doi: 10.1007/BF00570891.

引用本文的文献

1
Specific monoclonal antibody productivity and the cell cycle-comparisons of batch, continuous and perfusion cultures.
Cytotechnology. 1992;9(1-3):85-97. doi: 10.1007/BF02521735.